Join
Live feed
·
INSIDERFilingvia Quantisnow
Zymeworks Inc. logo

Chief Scientific Officer Moore Paul Andrew converted options into 37,168 shares and sold $504,699 worth of shares (20,110 units at $25.10), increasing direct ownership by 73% to 40,391 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ZYME (Zymeworks Inc.) and more on Quantisnow.

Chief Scientific Officer Moore Paul Andrew converted options into 37,168 shares and sold $504,699 worth of shares (20,110 units at $25.10), increasing direct ownership by 73% to 40,391 units (SEC Form 4) | Quantisnow